Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancement of Treatment of Delusions in Schizophrenia Through Neuromodulation

NCT03062553 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT03062553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03062553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancement of Treatment of Delusions in Schizophrenia Through Neuromodulation
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Withdrawn
Start date
February 1, 2019
Completion date
December 15, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delusions, psychosis, schizophrenia